Spyglass Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $33.9M | Sell |
|
|||||
|
2022
Q4 | $33.5M | Sell |
|
|||||
|
2022
Q3 | $66.6M | Sell |
|
|||||
|
2022
Q2 | $85.2M | Sell |
|
|||||
|
2022
Q1 | $143M | Sell |
|
|||||
|
2021
Q4 | $127M | Sell |
|
|||||
|
2021
Q3 | $124M | Buy |
|
|||||
|
2021
Q2 | $129M | Buy |
|
|||||
|
2021
Q1 | $139M | Buy |
|
|||||
|
2020
Q4 | $118M | Buy |
|
|||||
|
2020
Q3 | $109M | Buy |
|
|||||
|
2020
Q2 | $80.3M | Buy |
|
|||||
|
2020
Q1 | $39.9M | Buy |
|
|||||
|
2019
Q4 | $38.8M | Buy |
|
|||||
|
2019
Q3 | $17.4M | Buy |
|
|||||
|
2019
Q2 | $16.5M | Buy |
|
|||||
|
2019
Q1 | $9.07M | Buy |
|
|||||
|
2018
Q4 | $5.17M | Buy |
|